Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Clin Cancer Res. 2023 May 1;29(9):1678–1688. doi: 10.1158/1078-0432.CCR-22-3168

Figure 2: anti-MUC1 IgG Levels:

Figure 2:

(A) among MUC1 vaccine recipients with an immune response (N=13); (B) Fold elevation in anti MUC1 IgG among vaccine recipients with an immune response; (C) among vaccine recipients without an immune response (N=39); (C) among placebo controls (N=50). Arrows indicate timing of vaccine administration. Blood sampling occurred at the weeks enumerated on the X-axis. Results are shown for 1:80 plasma dilution.